SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-033374
Filing Date
2021-03-08
Accepted
2021-03-08 17:20:45
Documents
2
Period of Report
2021-03-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm218951d1_8k.htm 8-K 21695
2 EXHIBIT 99.1 tm218951d1_ex99-1.htm EX-99.1 87700
  Complete submission text file 0001104659-21-033374.txt   110493
Mailing Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103
Business Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103 267-765-3222
IBERE PHARMACEUTICALS (Filer) CIK: 0001835205 (see all company filings)

IRS No.: 981564986 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40119 | Film No.: 21722996
SIC: 6770 Blank Checks